Iterum Therapeutics PLC ITRMF
0.00
0.00
NaN
as of 24 Sep
- Market cap
- $1.6M
- P/E
- 0.0×
Follow ITRMF
Insider Buys
alert about insiders buying in the last 12 month
| Sep '25 | Jun '25 | Mar '25 | Dec '24 | Older periods | |
|---|---|---|---|---|---|
| 285.48% | 325.35% | 518.47% | 472.61% |
+8 more TTM periods Free account |
|
| (111.35%) | (99.93%) | (85.79%) | (69.93%) | ||
ROIC |
(455.51%) | (297.39%) | (184.61%) | 0.00% | |
Return on Tangible Assets |
(368.57%) | (256.98%) | (227.85%) | (343.84%) | |
Average Days of Receivables |
177.74 | — | — | 0.00 | |
Free Cash Flow per Share |
(0.43) | (0.37) | (0.49) | (1.36) | |
Free Cash Flow |
(19.53) | (14.74) | (16.75) | (26.77) | |
Capital Expenditures |
(0.01) | 0.00 | 0.00 | 0.00 | |
Piotroski F-Score |
2.00 | 1.00 | 1.00 | — | |
| Other line items | |||||
Cash ROIC |
(78.57%) | (49.47%) | (54.37%) | (66.35%) | |
Accounts Receivable Turnover |
3.79 | — | — | 0.00 | |
Accounts Payable Turnover |
1.62 | 1.55 | 0.98 | 0.00 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | — | |
Average Days of Payables |
184.26 | 278.02 | 91.25 | 0.00 | |
Days of Inventory on Hand |
366.92 | 221.67 | 117.76 | — | |
Tax Rate |
0.01 | 0.01 | 0.01 | 0.01 | |
Research and Development Expense of Revenue |
451.20% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
1,692.28% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
28.15% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.72 | 0.61 | 0.74 | 1.08 | |
Depreciation/Fixed assets |
115.83 | 192.75 | 141.06 | 111.83 | |
Capex/Depreciation |
(0.01) | 0.00 | 0.00 | 0.00 | |
Revenue per Share |
0.02 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.43) | (0.37) | (0.49) | (1.36) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.02 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
(2,930.54%) | 0.00% | 0.00% | 0.00% |
Columns are period end dates